Life Science and Technology
Latest round
- Series A
Last raised
- Mar 2016
Total raised
- $2.3M
Investors
- 1
About Life Science and Technology
Life Science and Technology specializes in cell and gene therapies, focusing on innovative treatments for severe medical conditions.Founded in 2013 by Baowen Chen, Life Science and Technology operates out of Shanghai, China, where it engages in the research and development of innovative cell and gene therapies., Ltd. specializes in the discovery, research, development, and manufacturing of innovative cell and gene therapies (CGT). The company's core offerings include a range of cell-based and gene-based treatments designed to address severe medical conditions with significant treatment limitations, such as idiopathic pulmonary fibrosis, diabetes-related kidney disease, and various types of solid tumors. Utilizing advanced technologies such as the LF-ToolBox platform, the company provides comprehensive solutions for drug development, including molecular cloning tools and stable lentiviral vectors., Ltd. generates revenue primarily through collaborations and partnerships with academic institutions and healthcare organizations. The transaction structure typically involves B2B agreements where the company offers its specialized products and services directly to hospitals and research entities, facilitating clinical trials and treatment applications. Pricing models are based on the nature of the service, which may include fees for clinical trial support, product supply, and technological licensing agreements for their proprietary CGT platform. Specifically, the company aims to introduce new cell and gene therapy products over the next few years, targeting markets in North America and Europe by 2025. This expansion will be supported by the advanced technologies being developed through their LF-ToolBox platform, ensuring a comprehensive suite of solutions for healthcare providers. The company is focused on solidifying partnerships with more hospitals and research institutions to facilitate clinical trials and expand its treatment applications.
Who invested in Life Science and Technology
1 investor across 1 round
See all investors in Life Science and Technology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 22, 2016
Amount
$2.3M
Investors
Questions about Life Science and Technology
Who invested in Life Science and Technology?
Life Science and Technology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Life Science and Technology raised?
Life Science and Technology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Life Science and Technology last raise money?
Life Science and Technology's most recent round on record is a Series A, in Mar 2016.
What does Life Science and Technology do?
Life Science and Technology specializes in cell and gene therapies, focusing on innovative treatments for severe medical conditions.
Where is Life Science and Technology headquartered?
Life Science and Technology is headquartered in Shanghai, China.
Which VCs invest in companies like Life Science and Technology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare it companies at Life Science and Technology's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Life Science and Technology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.